Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Biochemical and Biophysical Research Communications|June 17, 2009
All-trans retinoic acid-induced ADAM28 degrades proteoglycans in human chondrocytesYuichi Hikichi, Koji Yoshimura, Masaharu TakigawaJournal of Gastroenterology|December 13, 2006
Differential gene expression between flat adenoma and normal mucosa in the colon in a microarray analysisHiroto Kita, Yuichi Hikichi, Kouki Hikami, et al.Molecular Cancer Therapeutics|December 23, 2011
TAK-960, a novel, orally available, selective inhibitor of polo-like kinase 1, shows broad-spectrum preclinical antitumor activity in multiple dosing regimensYuichi Hikichi, Kohei Honda, Kouki Hikami, et al.Npj Biomedical Innovations|April 24, 2026
Accelerating personalized medicine: miniaturized patient-derived organoid drug screening for predicting cancer treatment responses and beyondYasmine Abouleila, Lidwien P Smabers, Timo Voskuilen, et al.Bioorganic & Medicinal Chemistry Letters|February 8, 2017
Structure-based design and SAR development of 5,6-dihydroimidazolo[1,5-f]pteridine derivatives as novel Polo-like kinase-1 inhibitorsAndre Kiryanov, Srinivasa Natala, Benjamin Jones, et al.Bioorganic & Medicinal Chemistry Letters|May 14, 2013
Discovery of TAK-960: an orally available small molecule inhibitor of polo-like kinase 1 (PLK1)Zhe Nie, Victoria Feher, Srinivasa Natala, et al.Pageof 1